|
Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in the ODYSSEY CHOICE I trial |
|
|
|
Titel: |
Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in the ODYSSEY CHOICE I trial |
Auteur: |
Roth, Eli M. Kastelein, John J.P. Cannon, Christopher P. Farnier, Michel McKenney, James M. DiCioccio, A. Thomas Brunet, Aurélie Manvelian, Garen Sasiela, William J. Baccara-Dinet, Marie T. Zhao, Jian Robinson, Jennifer G. |
Verschenen in: |
Journal of clinical lipidology |
Paginering: |
Jaargang 14 () nr. 5 pagina's 707-719 |
Jaar: |
2020 |
Inhoud: |
|
Uitgever: |
National Lipid Association |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|